Pharmacomicrobiomics

Pharmacomicrobiomics is a new field of research that focuses on the linkages between the microbiome and xenobiotic reaction, defined as the impact of changes in the microbiome on drug action and toxicity. It's a new discipline that examines how medications interact with the microbiome, and it's becoming a more essential aspect in predicting therapeutic responses in a variety of medical subspecialties. Pharmacomicrobiomics, or the study of interactions between the microbiome and pharmaceutical drugs, has demonstrated that the microbiome plays an important role in modifying medication response and changing therapeutic outcomes. Pharmacomicrobiomics could be utilised with rheumatic precision medicine techniques. According to new research, one out of every four drugs we use to treat non-intestinal ailments alters the gut microbiome, creating negative health effects and an increase in bacterial resistance. Furthermore, drug–microbial interactions have been shown to occur mostly in the colon, where medications can impact the intestinal milieu, microbial metabolism, and bacterial growth through changing the microbial community makeup. Because of this intricacy, pharmacological research necessitates a molecular biology approach that examines cell signaling as well as the complicated host–microbe–drug interactions. As a result, knowing how the microbiome influences medication responses necessitates research into the notion of pharmacomicrobiotics.

• Drug-Microbiome Interactions
• Human Gut Microbiota and Their Metabolites
• Intestinal Microbiota in The Pharmacokinetic Mechanisms
• Mechanism of The Microbiome to Drug Response
• Pharmacogenomics